Form 4: AVNS Officer Sells 15,000 Shares Under 10b5-1 Plan

AVANOS MEDICAL, INC. SVP and Chief Commercial Officer Kerr Holbrook sold 15,000 shares of common stock through pre-arranged trading plans.

Summary

• Kerr Holbrook, SVP, Chief Commercial Officer of AVANOS MEDICAL, INC. (AVNS), sold a total of 15,000 shares of common stock.
• The sales occurred on November 18, 2025, at prices ranging from $11.00 to $11.02 per share.
• These transactions were executed under a Rule 10b5-1(c) pre-arranged trading plan.
• Following these transactions, Kerr Holbrook beneficially owns 83,860 shares of AVNS common stock.

Sentiment

Score: 4

Explanation: The sentiment is slightly negative due to insider selling, but mitigated by the fact it was executed under a pre-arranged 10b5-1 plan, which suggests it's not a reaction to new, undisclosed negative information.

Positives

• The transactions were conducted under a Rule 10b5-1(c) plan, indicating a pre-scheduled sale rather than a reaction to recent company news.

Negatives

• An insider sale, even under a 10b5-1 plan, reduces the officer's direct equity stake in the company.
• The sale of 15,000 shares represents a reduction in the officer's beneficial ownership from 98,860 shares to 83,860 shares.

Risks

• While executed under a 10b5-1 plan, significant insider selling could be perceived by some investors as a lack of confidence in the company's future prospects, potentially leading to negative market sentiment.

Future Outlook

NA

Industry Context

NA

Stakeholder Impact

• Shareholders may interpret the insider sale as a slight negative signal, though the 10b5-1 plan mitigates concerns about immediate adverse news.

Key Dates

Recommendation

While an insider sale typically warrants caution, the execution under a Rule 10b5-1 plan suggests a pre-planned liquidity event rather than a reaction to new negative information. Investors should monitor future insider activity and company performance, but this single transaction does not fundamentally alter the investment thesis without further context.

Keywords

AVANOS MEDICAL, AVNS, Kerr Holbrook, Insider Sale, Form 4, 10b5-1 Plan, Officer Transaction, Common Stock